DNA test could prevent dangerous reactions to Kids' antidepressants
NCT ID NCT06763081
Summary
This study aims to find genetic markers that can predict which children and young adults might experience a troubling side effect called 'behavioral activation' from common antidepressant medications (SSRIs). Researchers will compare the DNA of 160 young people (ages 6-24) who either did or did not experience this side effect. The goal is to create a future genetic test that helps doctors choose safer treatments for depression, anxiety, and OCD.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY DISORDERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shared Health Facilities
RECRUITINGWinnipeg, Manitoba, R3C 3H8, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Manitoba College of Pharmacy
RECRUITINGWinnipeg, Manitoba, R3E 0T5, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.